Serotype 3 Polysaccharide-Protein Conjugates for Consistent Immunogenicity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for preparing polysaccharide-protein conjugates, particularly those using Streptococcus pneumoniae serotype 3 polysaccharide, suffer from low immunogenicity and inconsistency in conjugation efficiency, which is critical for effective vaccines in infants and the elderly.
Innovation Solution
A method involving the activation of Streptococcus pneumoniae serotype 3 polysaccharide with sodium metaperiodate in a specific pH and temperature range, followed by reductive amination with a cyanoborohydride salt and nickel(II) in an aqueous buffer, and subsequent purification to form high molecular weight conjugates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If prior art conjugation methods are used, then conjugation can be performed, but immunogenicity and consistency are insufficient
Solution Approach 1:
The patent applies parameter changes by optimizing pH (range 4.3-7.7) and temperature (range 2-10°C) during polysaccharide activation with sodium metaperiodate, and controlling conjugation conditions including nickel(II) concentration (0.5-15 mM) and cyanoborohydride salt ratio. These precise parameter controls resolve the contradiction by ensuring consistent immunogenicity while maintaining efficient conjugation.
2Productivity
If carrier protein concentration is increased to improve conjugation, then more conjugate can be formed, but cost and complexity increase
Solution Approach 1:
The patent employs self-service through catalytic nickel(II) ions that facilitate the reductive amination reaction without being consumed, and cyanoborohydride salt that automatically reduces imine intermediates. This resolves the contradiction by maximizing carrier protein utilization through efficient catalytic cycles without proportionally increasing process complexity.
3Productivity
If polysaccharide activation is performed under harsh conditions to increase reactivity, then conjugation efficiency improves, but polysaccharide degradation increases
Solution Approach 1:
The patent resolves this contradiction through parameter changes by conducting activation at mild temperatures (2-10°C) and controlled pH (4.3-7.7), which maintains polysaccharide integrity while sufficient reactivity is achieved through optimized sodium metaperiodate concentration and extended reaction time.
Solution Approach 2:
The patent applies beforehand cushioning by adding nickel(II) ions prior to cyanoborohydride to catalyze the reaction, and controlling the sequence of reagent addition. This protective approach ensures efficient conjugation while preventing polysaccharide degradation through mild reaction conditions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enhances the immunogenicity and consistency of polysaccharide-protein conjugates, making them suitable for multivalent vaccines by maximizing carrier protein consumption and reducing degradation.
Implementation Method 1
reacting a serotype 3 polysaccharide with sodium metaperiodate
Implementation Method 2
reacting an activated polysaccharide with a carrier protein in an aqueous buffer in the presence of a cyanoborohydride salt
Data Source
Figure 1
AI summary
The present invention provides methods for making polysaccharide-protein conjugates in which polysaccharides, typically from bacteria, are conjugated to a carrier protein by reductive amination under conditions which improve conjugation reaction consistency, increase consumption of protein during conjugation reaction, generate conjugates of higher molecular weight, and/or reduce the levels of free cyanide in the conjugate reaction product. The polysaccharide-protein conjugates obtained using these methods are useful for inclusion in multivalent vaccines.